Diseases & Disorders
(G12)
IRS Verified
DX Registered
990 on File
HENRY SCHUELER 41 & 9 FOUNDATION
Financial strength (30%)
82/100
Reliability (20%)
50/100
Effectiveness (25%)
68/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Acting on Henry’s request, the foundation’s goal is to provide funding toward innovative, leading-edge research in the field of pediatric high risk leukemia and the fungal infections children are at risk for contracting while their body’s immune systems are compromised during chemotherapy treatment. In doing so, we will save future -Henry’s- and their families from the same suffering we experienced. The donations given to the 41 & 9 Foundation are used to fund this important research and work with specialists from around the world to change the future. The Board of Directors also awards scholarships in Hank’s name to outstanding student athletes to further their studies.
Financial Overview — FY 2024
$489K
Total Revenue
$439K
Total Expenses
$807K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
73.3%
Fundraising Efficiency
N/A
Operating Reserve
22.06x
Liability-to-Asset
0.0%
Revenue Diversification
95.8%
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
73.3% | 83.1% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.1% | 10.9% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
23.6% | 0.3% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
22.1 mo | 12.0 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.7% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.8% | 93.9% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-2.5% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.3% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.2% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $489K | $439K | $807K | 73.3% | 0 |
| 2023 | $501K | $413K | $757K | 78.5% | 0 |
| 2022 | $498K | $527K | $669K | 82.3% | 0 |
| 2021 | $325K | $217K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.